Wave life sciences announces submission of first clinical trial application for wve-007 (sirna targeting inhbe) in obesity

Wve-007 is a novel approach for treating obesity and is designed to silence inhbe to achieve healthy, sustainable weight loss through fat burning, muscle maintenance and the potential for once or twice-annual administration
WVE Ratings Summary
WVE Quant Ranking